(Q42606039)

English

Safety, efficacy and pharmacokinetics of ritonavir 400mg/saquinavir 400mg twice daily plus rifampicin combined therapy in HIV patients with tuberculosis

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Safety, efficacy and pharmacokinetics of ritonavir 400mg/saquinavir 400mg twice daily plus rifampicin combined therapy in HIV patients with tuberculosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1 reference

based on heuristic

1 reference

based on heuristic

1 reference

based on heuristic

1 reference

based on heuristic

pharmacokinetics

1 reference

based on heuristic

Mariza Gonçalves Morgado

6

object named as

Mariza Gonçalves Morgado

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

author name string

Valeria Cavalcanti Rolla

1

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Maria A da Silva Vieira

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Douglas Pereira Pinto

3

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Maria C Lourenço

4

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Carlos da Silva de Jesus

5

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Milton Ferreira Filho

7

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Eduardo Werneck-Barroso

8

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

469-479

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycobacteremia in patients with the acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and survival in advanced AIDS in Rio de Janeiro, Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ritonavir enables combined therapy with rifampin and saquinavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuberculosis in patients with human immunodeficiency virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro evaluation of the effect of temporary removal of HIV drug pressure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malabsorption of antituberculosis medications by a patient with AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on rifampin drug interactions, III.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200626080-00005

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42606039&oldid=2144491047"